Navigation Links
MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results
Date:8/3/2009

MOUNTAIN VIEW, Calif., Aug. 3 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the second quarter ended June 30, 2009.

The net loss for the quarter ended June 30, 2009 was $5.0 million, compared to $16.5 million during the same period in 2008. The net loss for the first six months of 2009 was $14.9 million, compared to $30.8 million for the first six months of 2008. As of June 30, 2009, MAP Pharmaceuticals had cash, cash equivalents, short-term investments and accounts receivables of $59.9 million.

"We are very pleased that in the first Phase 3 trial for our LEVADEX(TM) migraine therapy, all four primary endpoints were met with statistical significance," said Timothy S. Nelson, President and Chief Executive Officer of MAP Pharmaceuticals. "With these positive results in hand and our recent decision to suspend development of Unit Dose Budesonide (UDB), we are now focusing our efforts on the development of LEVADEX. We believe that LEVADEX has a differentiated profile, with the potential to provide rapid and sustained relief of migraine symptoms, and could offer benefit to many of the approximately 30 million migraine sufferers in the U.S., including many who are not helped by currently available migraine therapies. We look forward to presenting the data from our successful Phase 3 trial of LEVADEX at the 14th Congress of the International Headache Society in September."

Second Quarter and Six Month Financial Results

Revenues for the quarter and six months ended June 30, 2009 were $8.6 million and $16.1 million, respectively, compared to $0 for the same periods in 2008. The collaboration revenue to date in 2009 was due to the amortization of a $40.0 million upfront payment received in February
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 2015 , ... One of the world’s leading experts on ... lifesaving impact of removing aluminum from Alzheimer’s disease patients, announced the Children’s ... on a successful pilot study published in The Journal of Alzheimer’s Disease in ...
(Date:7/29/2015)... ... July 29, 2015 , ... ITW ... oversees. In her role, Powers is responsible for driving growth and innovation across ... commented, “Gina’s track record as an effective leader within the ITW community speaks ...
(Date:7/28/2015)... ... ... City Sports, a specialty sports retailer and a premiere destination for dedicated ... , Hanaka, who has served on the Board of Directors for City Sports since ... Fund has had previous tenures as Chairman and CEO of Golfsmith International Holdings, Inc., ...
(Date:7/28/2015)... ... 28, 2015 , ... The Memorial Cardiac and Vascular Institute ... expert, streamlined total advanced heart care for the South Florida community. , The ... one roof, including the treatment of advanced heart failure, adult heart transplant, left ...
(Date:7/28/2015)... ... July 28, 2015 , ... Mindful Her, a unique ... to take their healthy and mindful living practices to the next level, announced today ... of Living with Intent as keynote. Global Girls, an Orange County based non-profit ...
Breaking Medicine News(10 mins):Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:City Sports Names Marty Hanaka CEO 2Health News:Memorial Cardiac And Vascular Institute Centralizes Cardiac Care Through It's New "Total Heart Center" At Memorial Regional Hospital 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3
... and it was the prime consideration when a team of ... lives. The Baby Bubbler or in its ... helps children with acute respiratory infections breathe naturally as ... percent of deaths in children under 5 are caused by ...
... The prevalence of mild sleep-disordered breathing in young ... will be presented Monday, June 7, 2010, in San ... of the Associated Professional Sleep Societies LLC. Results ... mild sleep-disordered breathing in elementary-school children increased steadily from ...
... build up a big sweat to reap the healing ... a low-intense exercise program can reduce depression symptoms and ... "The power of physical activity to raise the ... suspected," Heart and Stroke Foundation researcher Dr. Jocelyn Harris ...
... are uncommon as children enter adolescence, parasomnias present in ... a research abstract that will be presented Monday, June ... the 24th annual meeting of the Associated Professional Sleep ... persistence after five years was 29 percent for children ...
... professor in the department of biochemistry and organic chemistry ... this year,s recipient of the Georg Charles de Hevesy ... medicine profession. Lngstrm was presented the award by SNMan ... June 5𔃇, in Salt Lake City, Utah. ...
... undergoing treatment for melanoma that has spread to the ... the liver,s blood vessels, according to a study sponsored ... and led by James F. Pingpank, M.D., associate professor ... surgical oncologist with UPMC Cancer Centers. The results will ...
Cached Medicine News:Health News:Baby Bubbler a breath of fresh air 2Health News:Study finds a seasonal variance in sleep-disordered breathing in young children 2Health News:Non-intense physical activity to reduce depression and boost recovery of stroke patients 2Health News:Non-intense physical activity to reduce depression and boost recovery of stroke patients 3Health News:Childhood parasomnias such as sleepwalking and bedwetting may persist into adolescence 2Health News:Bengt Roland Långström receives SNM's 2010 Georg Charles de Hevesy Nuclear Pioneer Award 2Health News:New treatment method safe, effective for advanced melanoma patients 2
(Date:7/28/2015)... Amgen (NASDAQ: AMGN ) announced that ... share dividend for the third quarter of 2015. The ... all stockholders of record as of the close of ... Amgen Amgen is committed to unlocking the potential of ... developing, manufacturing and delivering innovative human therapeutics. This approach ...
(Date:7/28/2015)... 2015   Regulus Therapeutics Inc . ( NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... quarter ended June 30, 2015 on Tuesday, August 4, ... Regulus will host a conference call and webcast ... Daylight Time to discuss its second quarter 2015 financial ...
(Date:7/28/2015)... July 28, 2015 On the afternoon of ... company of CPI International, Inc. (CPI), plans to file ... 3, 2015 with the Securities and Exchange Commission and ... the quarter.  At 11 a.m. (EDT) on Wednesday, August ... in conjunction with this release that will be Web ...
Breaking Medicine Technology:Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3CPI International To Announce Third Quarter 2015 Financial Results 2
... PARK, N.C. & GENEVA--(BUSINESS WIRE)--Jul 11,2007 ... research and,development program for Plasmin (Human), ... this week at the XXIst International,Society ... in Geneva,Switzerland. The information included new ...
... WIRE)--Jul 11, 2007 - BioSante,Pharmaceuticals, Inc. (Amex: ... its calcium phosphate (CaP),nanoparticle-based vaccine adjuvant, BioVant(TM), ... the development of a dose sparing,vaccine against ... flu., The new results are based on ...
Cached Medicine Technology:New Information on the Potential of Plasmin Shared at ISTH Congress 2New Information on the Potential of Plasmin Shared at ISTH Congress 3New Information on the Potential of Plasmin Shared at ISTH Congress 4BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 2BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 3BioSante Pharmaceuticals Announces New Findings for Potential Bird,Flu Vaccine 4
The 6.5mm cannulated cancellous ACE SCFE Screw is specifically designed for the treatment of slipped capital femoral epiphysis. The ACE SCFE Screw simplifies insertion and facilitates removal....
The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
Smith & Nephew offers a wide variety of cannulated screw products. Most screw sizes are available in both partially threaded and fully threaded versions. , ,All systems optimize implant strength with...
Biomet® Arthrodesis Nail indications include: , Failed external fixation , Aseptic failed total knee arthroplasty , Periarticular fractures where repair is not possible , Limb salvage in tumor...
Medicine Products: